Ignite Creation Date:
2024-05-05 @ 7:38 PM
Last Modification Date:
2024-10-26 @ 9:52 AM
Study NCT ID:
NCT00715208
Status:
COMPLETED
Last Update Posted:
2013-04-29
First Post:
2008-07-11
Brief Title:
Phase 2 Study of VELCADE Bortezomib in Patients With Relapsed Follicular Lymphoma
Sponsor:
Millennium Pharmaceuticals Inc
Organization:
Millennium Pharmaceuticals Inc
Organization Data
Organization:
Millennium Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
C05012
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Millennium Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None